(IBIK) iShares Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Target Maturity
IBIK: Inflation-Protected Securities, TIPS, Exchange-Traded Fund
The iShares Trust (NYSE ARCA:IBIK) is an exchange-traded fund that aims to replicate the performance of a specific segment of the U.S. Treasury Inflation-Protected Securities (TIPS) market. The underlying index it tracks comprises TIPS with maturities between January 1, 2034, and October 15, 2034, making it a target maturity ETF focused on a specific date range.
By investing at least 80% of its assets in the component securities of the underlying index, the fund provides investors with a relatively pure play on the TIPS market for the specified maturity period. This can be particularly appealing to investors seeking to match their long-term liabilities or to hedge against inflation risks in their portfolios.
From a technical analysis perspective, the current price of IBIK is $25.29, slightly below its 20-day simple moving average (SMA) of $25.37 and above its 200-day SMA of $25.05. The Average True Range (ATR) indicates a daily volatility of 0.90%, suggesting relatively stable trading conditions. Given the narrow range between the 52-week high ($25.77) and the current price, and considering the funds proximity to its SMAs, a potential forecast could involve a slight upward movement towards the 52-week high, driven by the funds tracking performance and the overall trend in the TIPS market.
Combining the technical analysis with fundamental data, such as the funds Assets Under Management (AUM) of $41.74M USD, suggests that while the fund is not among the largest ETFs, it still maintains a viable presence in the market. The relatively stable AUM, coupled with the technical indicators, could imply a steady investor interest. A forecast based on both technical and fundamental data might suggest that IBIK could continue to track the underlying TIPS index closely, potentially moving towards the upper end of its 52-week range if inflation expectations remain a significant market driver.
Investors considering IBIK should monitor inflation trends and Treasury market dynamics closely, as these factors will significantly influence the funds performance. The funds target maturity date in 2034 makes it a potential component in long-term investment strategies, particularly for those seeking to manage inflation risk.
Additional Sources for IBIK ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBIK ETF Overview
Market Cap in USD | 42m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2024-05-22 |
IBIK ETF Ratings
Growth Rating | 32.6 |
Fundamental | - |
Dividend Rating | 30.3 |
Rel. Strength | -6.34 |
Analysts | - |
Fair Price Momentum | 23.94 USD |
Fair Price DCF | - |
IBIK Dividends
Dividend Yield 12m | 3.68% |
Yield on Cost 5y | 3.83% |
Annual Growth 5y | -37.07% |
Payout Consistency | 100.0% |
IBIK Growth Ratios
Growth Correlation 3m | 9.5% |
Growth Correlation 12m | 45.3% |
Growth Correlation 5y | 45.3% |
CAGR 5y | 4.42% |
CAGR/Max DD 5y | 0.79 |
Sharpe Ratio 12m | 0.91 |
Alpha | 0.26 |
Beta | -0.005 |
Volatility | 6.34% |
Current Volume | 8k |
Average Volume 20d | 6.5k |
As of May 22, 2025, the stock is trading at USD 25.10 with a total of 8,049 shares traded.
Over the past week, the price has changed by -0.45%, over one month by +0.41%, over three months by +0.30% and over the past year by +4.42%.
Neither. Based on ValueRay Analyses, iShares Trust is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.63 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBIK as of May 2025 is 23.94. This means that IBIK is currently overvalued and has a potential downside of -4.62%.
iShares Trust has no consensus analysts rating.
According to ValueRays Forecast Model, IBIK iShares Trust will be worth about 25.9 in May 2026. The stock is currently trading at 25.10. This means that the stock has a potential upside of +3.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.9 | 3% |